Abbott Laboratories Com Stk NPV (NYSE:ABT)
Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
reachmygoals1
(< 20)
Submitted: 2/12/2012 12:56:22 AM :
Start Price:
$55.18
ABT Score:
-0.02
great biotech with dividends
Recs
toaoyoda
(39.42)
Submitted: 2/10/2012 2:47:45 PM :
Start Price:
$55.06
ABT Score:
-0.67
ABT has been a stellar performer for decades but the upcoming splitup will enhance shareholder value even more. The pharma business will be spun off to showcase the greater PE ratio appropriate to a purer play. Meanwhile, ABT's core businesses of diagnostic, nutrition and medical devices will receive the focus of both management (Miles White will remain with the core ) and investors. ABT is not often recognized as what used to be called a "Japanese manufacturing company" with continual improvements in productivity and quality built into its managerial incentive system. The company has been hit by mfg problems at individual plants in the past but these are one-off problems and not reflective of the overall mfg prowess of this company.
Recs
rjs157
(50.78)
Submitted: 2/7/2012 5:40:39 PM :
Start Price:
$55.82
ABT Score:
-1.51
Diversified healthcare co., aging population, dividend king, great long term growth potential.
Recs
jdwelch62
(24.75)
Submitted: 2/1/2012 11:57:07 AM :
Start Price:
$54.16
ABT Score:
-0.09
Great pharma giant and medical device company. Solid, safe yield. Looking forward to see what happens when they split their pharmaceuticals from medical devices, etc., into 2 separate companies.
Recs
ditcap
(53.43)
Submitted: 1/4/2012 10:56:29 AM :
Start Price:
$55.93
ABT Score:
-7.89
Hoping 2012 spin will create some value.
Recs
BillZack
(41.06)
Submitted: 12/29/2011 3:31:28 PM :
Start Price:
$55.83
ABT Score:
+8.53
Looks oversold and due for a short term pull-back before taking the next leg up.
Recs
Monroe7
(36.79)
Submitted: 12/24/2011 10:00:08 AM :
Start Price:
$55.34
ABT Score:
-7.57
Nice growing dividend, established large cap
Recs
jzd999explosion
(78.70)
Submitted: 11/28/2011 5:36:23 PM :
Start Price:
$52.97
ABT Score:
-8.58
M* ultimate stockpickers
Recs
Recs
DollarDaze100
(< 20)
Submitted: 11/10/2011 7:43:49 PM :
Start Price:
$53.89
ABT Score:
-5.17
Healthcare is roughly 16% of the GDP. The US model isn't the best but for right now the best companies can take advantage of the market, technology and demand. Keep an eye on this short/mid-term.
Recs
troym72
(45.55)
Submitted: 11/3/2011 9:55:55 AM :
Start Price:
$52.93
ABT Score:
-4.67
Abbot's forward P/E suggests that they will be worth close to $90 per share within the next 12 mos. That's nearly a 50% gain. Even if ABT doesn't maintain a P/E of 15 through 2012, I still think there is significant upside. They are also considering spinning off their Rx division from their Medical Instruments division. This news has helped the stock outperform recently as well.
Recs
kbynot1
(< 20)
Submitted: 10/29/2011 11:52:54 PM :
Start Price:
$53.09
ABT Score:
-2.51
The spin-off move will pay off big time.
Recs
stockstar69
(23.59)
Submitted: 10/24/2011 11:49:25 AM :
Start Price:
$53.03
ABT Score:
-4.72
The split that is to come, secure dividend, and the stock's history of realiability.
Recs
campwt00global
(86.36)
Submitted: 10/20/2011 1:54:25 PM :
Start Price:
$53.46
ABT Score:
-8.28
tmf royal
Recs
TMFRoyal
(98.89)
Submitted: 10/20/2011 1:23:01 PM :
Start Price:
$53.72
ABT Score:
-8.71
Things look perky following the announced spin-off news.
Recs
TMFDeej
(99.22)
Submitted: 10/19/2011 11:13:16 AM :
Start Price:
$53.57
ABT Score:
-7.50
Spin-off with a solid dividend.
Recs
ecco1011
(< 20)
Submitted: 10/4/2011 12:26:53 AM :
Start Price:
$49.11
ABT Score:
-12.27
Baby boomers will contribute to health care industry. ABT is selling at 10 times earnings. Pays dividends each quarter, has raised dividend each qtr for the past 40 yrs. Projected to grow earnings per share 11% per year for the next 5 years.
Recs
twocoins
(54.01)
Submitted: 10/3/2011 3:24:23 PM :
Start Price:
$49.35
ABT Score:
-10.86
Being an "Aristocrat" I am confident of continued dividend increases as well as higher prices as we pull out of this funk of a market that we are in,
Recs
Recs
esquarem
(74.94)
Submitted: 9/6/2011 6:00:57 PM :
Start Price:
$50.92
ABT Score:
-5.60
Good company and e/s growing and growing dividend.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 346 : 1 2 3 4 5 6 7 8 9 10 Next »